Despite doubts last year about human adult neurogenesis, a study shows even 80-year-olds develop new cells in the hippocampus, but such growth is diminished in patients with Alzheimer’s disease.
A study in rats finds that tiny doses of the psychedelic drug DMT may yield positive effects for anxiety and depression, but there could be downsides too.
The observation could pave the way for a blood test to predict disease progression in people with a genetic predisposition to developing the neurodegenerative disorder.
The PsychENCODE project delves into the DNA, RNA, and protein changes related to brain development and neuropsychiatric disorders, but researchers caution it’s just a first step toward treatment.
The EEG-based method could help clinicians identify patients with severe brain injuries who are actually capable of some cognitive function, despite appearing unresponsive.